SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 319 filers reported holding SALIX PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.43 and the average weighting 1.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2015 | $243,000 | -99.3% | 1,408 | -99.5% | 0.02% | -99.4% |
Q4 2014 | $34,399,000 | +3.2% | 299,276 | +40.2% | 3.01% | -8.1% |
Q3 2014 | $33,341,000 | +1.6% | 213,398 | -19.7% | 3.27% | +0.3% |
Q2 2014 | $32,801,000 | +19.5% | 265,915 | +0.4% | 3.26% | +16.1% |
Q1 2014 | $27,443,000 | +3.5% | 264,872 | -10.2% | 2.81% | -3.7% |
Q4 2013 | $26,521,000 | +33.8% | 294,876 | -0.5% | 2.92% | +2.1% |
Q3 2013 | $19,819,000 | +2038.0% | 296,340 | +2014.4% | 2.86% | +1869.7% |
Q2 2013 | $927,000 | – | 14,015 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 467,943 | $30,954,000 | 11.01% |
TANG CAPITAL MANAGEMENT LLC | 300,000 | $19,845,000 | 7.82% |
OAK RIDGE INVESTMENTS LLC | 1,382,895 | $91,478,000 | 2.87% |
SECTOR GAMMA AS | 147,001 | $9,724,000 | 2.84% |
Credo Capital Management, LLC | 38,869 | $2,571,000 | 1.98% |
Cardinal Capital Management | 48,226 | $3,190,000 | 1.89% |
ZEVENBERGEN CAPITAL INVESTMENTS LLC | 626,800 | $41,463,000 | 1.68% |
HERNDON CAPITAL MANAGEMENT LLC | 1,284,472 | $84,967,823,000 | 1.27% |
CATAPULT CAPITAL MANAGEMENT LLC | 45,000 | $2,977,000 | 1.24% |
Pier Capital, LLC | 108,556 | $7,181,000 | 1.10% |